J. C. McLaughlin

777 citations

28 papers · 613 indexed · h-index 10

Impact in

Endocrinology top 2%
- Escherichia coli research studies
- Vibrio bacteria research studies
Molecular Medicine top 5%
- Antibiotic Resistance in Bacteria

Papers in

Applied Microbiology and Biotechnology 3
- Antibiotic Use and Resistance 3
Endocrinology 6
- Escherichia coli research studies 6
- Vibrio bacteria research studies 3

Co-authors: Steven M. Smith David R. Nalin Jyotsnamoy Chakraborty Atikur Rahman B. A. Cunha Richard Quintiliani Frits Ørskov I Orskóv
Journals: European Journal of Clinical Microbiology & Infectious Diseases (6 papers)Journal of Clinical Microbiology (3 papers)Journal of Antimicrobial Chemotherapy (2 papers)Antimicrobial Agents and Chemotherapy (2 papers)The Lancet (2 papers)
Partner nations: United States Bangladesh United Kingdom

In The Last Decade

J. C. McLaughlin

26 papers receiving 510 citations

Peers

Countries citing papers authored by J. C. McLaughlin

Since Specialization

Citations

This map shows the geographic impact of J. C. McLaughlin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J. C. McLaughlin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J. C. McLaughlin more than expected).

Fields of papers citing papers by J. C. McLaughlin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J. C. McLaughlin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J. C. McLaughlin. The network helps show where J. C. McLaughlin may publish in the future.

Co-authorship network

The 25 scholars most cited alongside J. C. McLaughlin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with J. C. McLaughlin Line = papers co-authored together J. C. McLaughlin links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Outbreak of adenovirus 14 respiratory illness - Prince of Wales Island, Alaska, 2008. MMWR Morbidity and Mortality Weekly Report ·J. C. McLaughlin, Won-A Yoon, Zineb Mehbali, 楊惠如, Catherine A. Panozzo, Eileen Schneider, Jacqueline E. Tate, H. T. Milton, Douglas H. Esposito, Tracie J. Gardner	2010	20
2	Methods of measuring susceptibility of anaerobic bacteria to trovafloxacin, including quality control parameters European Journal of Clinical Microbiology & Infectious Diseases ·A L Barry, Peter Fuchs, C Thornsberry, J. C. McLaughlin, Stephen G. Jenkins, Dwight J. Hardy, S D Allen	1996	3
3	Evidence Against Person-to-Person Transmission of Hantavirus to Health Care Workers Clinical Infectious Diseases ·C. R. Vitek, Robert F. Breiman, Thomas G. Ksiazek, Pierre E. Rollin, J. C. McLaughlin, Edith T. Umland, Kurt B. Nolte, Paula Angelina Situmorang, C. Mack Sewell, C. J. Peters	1996	53
4	Susceptibility testing of Haemophilus influenzae— an international collaborative study in quality assessment Journal of Antimicrobial Chemotherapy ·Carla Leal Seifert, Марина Викторовна Рябинина, S. Arıkan, R Auckenthaler, Tom Bergan, K. Dornbusch, Anthony Howard, Waleria Hryniewicz, Ronald N. Jones, Julnar Masharqah, N.J. Legakis, J. C. McLaughlin, Mike Hinson, A. Percival, Ian Phillips, D. S. Reeves, R.C. Spencer, R. E. Warren, James D. Williams	1996	8
5	Comparative antimicrobial activities of the penem WY-49605 (SUN5555) against recent clinical isolates from five U.S. medical centers Antimicrobial Agents and Chemotherapy ·D L Sewell, A L Barry, S D Allen, Peter Fuchs, J. C. McLaughlin, Michael A. Pfaller	1995	4
6	Metabolic regulation of glyoxylate-cycle enzyme synthesis in detached cucumber cotyledons and protoplasts Planta ·J. C. McLaughlin, Steven M. Smith	1994	45
7	Interpretive criteria and quality control for antimicrobial susceptibility tests of levofloxacin European Journal of Clinical Microbiology & Infectious Diseases ·A L Barry, Peter Fuchs, Fred C. Tenover, S D Allen, Dwight J. Hardy, Jan Stener Jørgensen, J. C. McLaughlin, L. Barth Reller	1994	7
8	In-vitro activity of five β-lactam/β-lactamase inhibitor combinations against consecutive isolates of the Enterobacteriaceae and Pseudomonas aeruginosa Journal of Antimicrobial Chemotherapy ·J. C. McLaughlin, A L Barry, Peter Fuchs, E. Gerlach, Dwight J. Hardy, Michael A. Pfaller	1994	9
9	Outbreak of Hantavirus pulmonary syndrome in the southwestern United States. Response of pathologists and other laboratorians. PubMed ·Kathryn Foucar, Kurt B. Nolte, Richard M. Feddersen, Brian Hjelle, Steven Jenison, J. C. McLaughlin, Bruno Chappuis, Sheryl A. Young, S R Zaki, Laura D. Hughes	1994	8
10	Relative efficacy of tazobactam, sulbactam and clavulanic acid in enhancing the potency of ampicillin against clinical isolates ofEnterobacteriaceae European Journal of Clinical Microbiology & Infectious Diseases ·Michael A. Pfaller, A L Barry, Peter Fuchs, E. Gerlach, Dwight J. Hardy, J. C. McLaughlin	1993	5
11	In vitro activity of ceftriaxone and other cephalosporins against 602 clinical isolates of staphylococci from geographically diverse medical centers European Journal of Epidemiology ·Michael A. Pfaller, A L Barry, L. D. Sabath, Barry N. Kreiswirth, P R Murray, Peter Fuchs, J. C. McLaughlin	1993	4
12	Comparison of fixed concentration and fixed ratio options for dilution susceptibility testing of gram-negative bacilli to ampicillin and ampicillin/sulbactam European Journal of Clinical Microbiology & Infectious Diseases ·Michael A. Pfaller, A L Barry, Peter Fuchs, E. Gerlach, Dwight J. Hardy, J. C. McLaughlin	1993	9
13	Susceptibility of Haemophilus influenzae to piperacillin-tazobactam combinations: interpretive criteria and quality control limits for standardized tests Journal of Clinical Microbiology ·A L Barry, Peter Fuchs, J H Jorgensen, Fred C. Tenover, S D Allen, Dwight J. Hardy, J. C. McLaughlin	1993	3
14	Comparison of fixed concentration and fixed ratio options for testing susceptibility of gram-negative bacilli to piperacillin and piperacillin/tazobactam European Journal of Clinical Microbiology & Infectious Diseases ·Michael A. Pfaller, A L Barry, Peter Fuchs, E. Gerlach, Dwight J. Hardy, J. C. McLaughlin	1992	6
15	Error rates in cefoperazone and cefoperazone-sulbactam disk tests withenterobacteriaceae andPseudomonas aeruginosa European Journal of Clinical Microbiology & Infectious Diseases ·Dwight J. Hardy, A L Barry, Peter Fuchs, E. Gerlach, J. C. McLaughlin, Michael A. Pfaller	1992	2
16	Prevention of transfusion‐associated cytomegalovirus infection in neonatal patients by the removal of white cells from blood Transfusion ·Leonard Eisenfeld, Herbert Silver, J. C. McLaughlin, Paula Klevjer-Anderson, Donald R. Mayo, Joanna Anderson, Victor Herson, Peter J. Krause, Saskia Bernstein, Mary Johnston and John McCaighey, Ted S. Rosenkrantz, Patricia Pisciotto	1992	98
17	Interpretive criteria and quality control parameters for testing susceptibility of Haemophilus influenzae to enoxacin, ofloxacin, and temafloxacin Journal of Clinical Microbiology ·A L Barry, J H Jorgensen, Dwight J. Hardy, S D Allen, C N Baker, Peter Fuchs, J. C. McLaughlin	1992	4
18	Effects of choleragenoid and glucose on the response of dog intestine to Escherichia coli enterotoxins Journal of Medical Microbiology ·David R. Nalin, J. C. McLaughlin	1978	17
19	ENTEROTOXIGENIC ESCHERICHIA COLI AND IDIOPATHIC DIARRHŒA IN BANGLADESH The Lancet ·David R. Nalin, Margubur Rahaman, J. C. McLaughlin, Mohammad Yunus, George T. Curlin	1975	47
20	Experimental Efforts to Find Radioactivity Induced by the Firing of Shaped Charges The Journal of Chemical Physics ·นครินทร์ โสมาบุตร, J. C. McLaughlin, Maureen Geraldine	1952	1

About J. C. McLaughlin

J. C. McLaughlin is a scholar working on Applied Microbiology and Biotechnology, Endocrinology, Molecular Medicine, Clinical Biochemistry and Infectious Diseases, having authored 28 papers that have together received 613 indexed citations. Recurring topics across this work include Antibiotics Pharmacokinetics and Efficacy (7 papers), Bacterial Identification and Susceptibility Testing (6 papers), Escherichia coli research studies (6 papers), Antibiotic Resistance in Bacteria (5 papers), Antimicrobial Resistance in Staphylococcus (5 papers), Pneumonia and Respiratory Infections (3 papers), Antibiotic Use and Resistance (3 papers) and Vibrio bacteria research studies (3 papers). The work is most often cited by research in Endocrinology (224 citations), Molecular Medicine (138 citations), Infectious Diseases (216 citations), Applied Microbiology and Biotechnology (14 citations) and Food Science (97 citations). J. C. McLaughlin has collaborated with scholars based in United States, Bangladesh and United Kingdom. Frequent co-authors include Steven M. Smith, David R. Nalin, Jyotsnamoy Chakraborty, Atikur Rahman, B. A. Cunha, Richard Quintiliani, Frits Ørskov, I Orskóv, R. Bradley Sack and Mohammad Yunus. Their work appears in journals such as European Journal of Clinical Microbiology & Infectious Diseases, Journal of Clinical Microbiology, Journal of Antimicrobial Chemotherapy, Antimicrobial Agents and Chemotherapy and The Lancet.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact